 |
|
Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection
Roberto Álvarez-Lafuente, MD;
Virginia De las Heras, PhD;
Manuel Bartolomé, PhD;
Juan José Picazo, MD;
Rafael Arroyo, MD
Arch Neurol. 2004;61:1523-1527.
Background Recent studies have focused on the relationship between human herpesvirus 6 (HHV-6) and multiple sclerosis (MS).
Objective To analyze HHV-6 messenger RNA expression in patients with relapsing-remitting (RR) MS vs healthy blood donors (HBDs).
Design One hundred fifty-four subjects were enrolled in the study: 105 patients with RRMS (32 in relapse) and 49 HBDs. Total DNA and messenger RNA were extracted from serum and blood samples, respectively, and analyzed by quantitative real-time reverse transcription0dash;polymerase chain reaction for the detection of 3 HHV-6 immediate-early genes (U16/U17,U89/U90, and U94) and both HHV-6 variants (HHV-6A and HHV-6B).
Results Active HHV-6 infection was detected in 16% of patients with RRMS vs 0% of HBDs (P = .003). Seven patients with RRMS with exacerbation had HHV-6 active replication, and the virus remained latent in only 1 of them. We did not find any statistically significant difference between HHV-6 active or latent infection for patients in remission (P = .12). Among patients with RRMS with HHV-6 active replication, viral load was higher when they experienced an acute attack than when in remission (P = .04). In those patients with RRMS who had an active infection only, HHV-6A was found. Cell-free HHV-6 DNA detected in serum samples confirmed the results.
Conclusions The results show that a subset of patients with RRMS experience HHV-6 active infection, and there likely is an association between the viral active replication and relapses; therefore, HHV-6 active infection may imply a greater risk of exacerbations in a subgroup of patients with RRMS.
Author Affiliations: Servicio de Neurología (Drs Álvarez-Lafuente, De las Heras, Bartolomé, and Arroyo) and Servicio de Microbiología Clínica (Dr Picazo), Hospital Clínico San Carlos, Madrid, Spain.
RELATED ARTICLE
Viral Pathogens in Multiple Sclerosis: An Intriguing (Hi)story
Olaf Stüve, Michael Racke, and Bernhard Hemmer
Arch Neurol. 2004;61(10):1500-1502.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Human herpes virus 6 and multiple sclerosis: a Finnish twin study
Kuusisto et al.
Mult Scler 2008;14:54-58.
ABSTRACT
Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6
Mameli et al.
J. Gen. Virol. 2007;88:264-274.
ABSTRACT
| FULL TEXT
Demyelinating diseases.
Love
J. Clin. Pathol. 2006;59:1151-1159.
ABSTRACT
| FULL TEXT
Identification and Characterization of U83A Viral Chemokine, a Broad and Potent {beta}-Chemokine Agonist for Human CCRs with Unique Selectivity and Inhibition by Spliced Isoform
Dewin et al.
J. Immunol. 2006;176:544-556.
ABSTRACT
| FULL TEXT
Balo's concentric sclerosis associated with primary human herpesvirus 6 infection
Pohl et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1723-1725.
ABSTRACT
| FULL TEXT
TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes
Jack et al.
J. Immunol. 2005;175:4320-4330.
ABSTRACT
| FULL TEXT
Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter
Opsahl and Kennedy
Brain 2005;128:516-527.
ABSTRACT
| FULL TEXT
Viral Pathogens in Multiple Sclerosis: An Intriguing (Hi)story
Stuve et al.
Arch Neurol 2004;61:1500-1502.
FULL TEXT
|
